Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
108.4 USD | -0.07% |
|
+2.74% | -22.16% |
07-01 | RBC Lowers Price Target on Illumina to $242 From $249, Keeps Outperform Rating | MT |
07-01 | ANALYST RECOMMENDATIONS : Nvidia, Broadcom, Progressive, Draftkings, Moody's... | ![]() |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.16% | 17.28B | |
+1.10% | 206B | |
+3.74% | 177B | |
+31.64% | 157B | |
+31.82% | 112B | |
+1.56% | 64.63B | |
+20.85% | 55.63B | |
-3.54% | 47.57B | |
-9.01% | 36.87B | |
-0.36% | 35.18B |
- Stock Market
- Equities
- ILMN Stock
- News Illumina, Inc.
- Transcript : Illumina, Inc. Presents at JPMorgan 40th Annual Healthcare Conference, Jan-09-2022 through Jan-13-2022